Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dendrobium Huoshanense Suppository for Radiation Proctitis in Rectal Cancer
NCT05079438Phase 3Unknown
- Sponsor
- Zhejiang Cancer Hospital
- Start
- Sep 2021
- Primary completion
- Jul 2023
- Modality
- Recombinant Proteins and Enzymes, Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dendrobium huoshanense in radiation proctitis, sponsored by Zhejiang Cancer Hospital. Status: unknown.
02
Drugs
dendrobium huoshanense
03
Conditions
radiation proctitis
Beyond the preview
Go deeper on NCT05079438.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05079438.